We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Amyris, Genome Compiler Collaborate
News

Amyris, Genome Compiler Collaborate

Amyris, Genome Compiler Collaborate
News

Amyris, Genome Compiler Collaborate

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Amyris, Genome Compiler Collaborate"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The two companies announced a collaboration agreement in March 2015 to integrate Amyris’s automated lab services with Genome Compiler’s online design tools and e-commerce platform to enable users to design and order DNA or other biological products seamlessly. 

Researchers Can Achieve More – In Less Time at Lower Cost

Through the integrated platform, researchers can leverage a comprehensive solution from design to delivery that represents a first-of-its-kind integrated DNA design and construction service.  The service allows for greater levels of automation, enabling faster progress, and will be less expensive and more sophisticated than other available offerings. Prospective customers will have access to Genome Compiler’s advanced software tools, along with Amyris’s extensive libraries of verified genetic parts, DNA construction and editing methods, all derived from its expertise in innovative bioscience technology.

“Amyris’s leadership role in bioscience technology has enabled us to secure legacy expertise in DNA construction research and automation to speed development and reduce costs,” said Joel Cherry, President of Research & Development at Amryis. “Today, we are able to open up key aspects of our DNA design and construction platform services, technical aptitude and knowledge base in synch with Genome Compiler’s powerful software tools to provide a fully integrated platform for companies and others seeking to pursue synthetic biology solutions.”

“We’re pleased to announce the availability of this testing program with Amyris so quickly after announcing our partnership,” said Omri Amirav Drory, CEO of Genome Compiler. “We have been working closely with Amyris in recent months and are excited by what we have achieved in creating a truly integrated genomic research platform providing a unique outsourced solution for any organization’s synthetic biology development needs along with the ability to achieve significant time and cost savings.”

This joint project between Amyris and Genome Compiler has been funded in part by a grant from the Binational Industrial Research and Development Foundation (BIRD Foundation), a U.S.-Israeli partnership between private sectors to expand private high-tech industries.

Advertisement